Institutional investors purchased a net $175.7 thousand shares of TXMD during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 56.86% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 1.5 Million shares of TherapeuticsMD Inc
FRANKLIN ADVISERS, INC. Bought 730.8 Thousand shares of TherapeuticsMD Inc
SABBY CAPITAL LLC Bought 549.9 Thousand shares of TherapeuticsMD Inc